Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kim A. Margolin, MD
City of Hope Medical Center
Study Chair - Patrick J. Loehrer, MD
Indiana University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
153 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Hospital
Westmead, New South Wales, Australia
- Instituto de Enfermedades Neoplasicas
Lima, Peru
- San Juan City Hospital
San Juan, Puerto Rico
- University of Puerto Rico School of Medicine Medical Sciences Campus
San Juan, Puerto Rico
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- St. Joseph Hospital - Orange
Orange, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Veterans Affairs Medical Center - San Diego
San Diego, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco
San Francisco, California, United States
- Stanford University Medical Center
Stanford, California, United States
- John Muir Medical Center
Walnut Creek, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Lombardi Cancer Center
Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Washington, Dc
Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- Broward General Medical Center
Fort Lauderdale, Florida, United States
- Memorial Regional Hospital Comprehensive Cancer Center
Hollywood, Florida, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center
West Palm Beach, Florida, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Mountain States Tumor Institute
Boise, Idaho, United States
- Louis A. Weiss Memorial Hospital
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (westside Hospital)
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 1994
- Primary completion
- —
- Completion
- 31 Jul 2006
- Last update posted
- 26 Jun 2013
- Registered enrollment
- 270
- Registry id
- NCT00002596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.